Mrs Michelle Parish, APRN - Medicare Nurse Practitioner in Little Rock, AR

Mrs Michelle Parish, APRN is a medicare enrolled "Nurse Practitioner - Family" in Little Rock, Arkansas. She graduated from nursing school in 2017 and has 7 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Dr Q Pain And Spine Clinic Pa and her current practice location is 5700 W Markham St, Little Rock, Arkansas. You can reach out to her office (for appointments etc.) via phone at (501) 227-0184.

Mrs Michelle Parish is licensed to practice in Arkansas (license number A005539) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1003302639.

Contact Information

Mrs Michelle Parish, APRN
5700 W Markham St,
Little Rock, AR 72205
(501) 227-0184
Not Available



Provider's Profile

Full NameMrs Michelle Parish
GenderFemale
SpecialityNurse Practitioner
Experience7 Years
Location5700 W Markham St, Little Rock, Arkansas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mrs Michelle Parish graduated from nursing school in 2017
  NPI Data:
  • NPI Number: 1003302639
  • Provider Enumeration Date: 07/06/2018
  • Last Update Date: 07/23/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 6608126859
  • Enrollment ID: I20180910000270

Medical Identifiers

Medical identifiers for Mrs Michelle Parish such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003302639NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family A005539 (Arkansas)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Dr Q Pain And Spine Clinic Pa105245066511

News Archive

UCSF scientists explore how Dact1 mutations contribute to psychiatric disorders

Gene mutations that cause cell signaling networks to go awry during embryonic development and lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism, and bipolar disorder, according to new research by UC San Francisco scientists.

Spider venom peptide could help stop pain in irritable bowel syndrome

Their study titled, "A spider-venom peptide with multi-target activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome," is published in the latest issue of the journal Pain.

Interleukin Genetics transfers stock trading from NYSE Amex to OTCQB Marketplace

Interleukin Genetics, Inc. today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics' symbol will now be ILIU.

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

G8 Summit begins Wednesday; WFP calls for 'twin-track' approach to food security

The G8 summit is scheduled to open Wednesday in L'Aquila, Italy. The World Food Program (WFP) on Tuesday issued a statement praising the G8 leaders' focus on food security and calling for support of its efforts to combat hunger among the world's poorest people, Xinhua reports. In the statement, WFP Executive Director Josette Sheeran recommended leaders take a "twin-track" approach to food security, which includes supporting long-term agricultural production along with immediate hunger assistance.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mrs Michelle Parish allows following entities to bill medicare on her behalf.
Entity NameDr Q Pain & Spine Clinic Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477781425
PECOS PAC ID: 1052450665
Enrollment ID: O20091120000013

News Archive

UCSF scientists explore how Dact1 mutations contribute to psychiatric disorders

Gene mutations that cause cell signaling networks to go awry during embryonic development and lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism, and bipolar disorder, according to new research by UC San Francisco scientists.

Spider venom peptide could help stop pain in irritable bowel syndrome

Their study titled, "A spider-venom peptide with multi-target activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome," is published in the latest issue of the journal Pain.

Interleukin Genetics transfers stock trading from NYSE Amex to OTCQB Marketplace

Interleukin Genetics, Inc. today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics' symbol will now be ILIU.

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

G8 Summit begins Wednesday; WFP calls for 'twin-track' approach to food security

The G8 summit is scheduled to open Wednesday in L'Aquila, Italy. The World Food Program (WFP) on Tuesday issued a statement praising the G8 leaders' focus on food security and calling for support of its efforts to combat hunger among the world's poorest people, Xinhua reports. In the statement, WFP Executive Director Josette Sheeran recommended leaders take a "twin-track" approach to food security, which includes supporting long-term agricultural production along with immediate hunger assistance.

Read more Medical News

› Verified 5 days ago

Entity NameSignify Health Medical Associates Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750845863
PECOS PAC ID: 2163764424
Enrollment ID: O20190913002365

News Archive

UCSF scientists explore how Dact1 mutations contribute to psychiatric disorders

Gene mutations that cause cell signaling networks to go awry during embryonic development and lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism, and bipolar disorder, according to new research by UC San Francisco scientists.

Spider venom peptide could help stop pain in irritable bowel syndrome

Their study titled, "A spider-venom peptide with multi-target activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome," is published in the latest issue of the journal Pain.

Interleukin Genetics transfers stock trading from NYSE Amex to OTCQB Marketplace

Interleukin Genetics, Inc. today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics' symbol will now be ILIU.

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

G8 Summit begins Wednesday; WFP calls for 'twin-track' approach to food security

The G8 summit is scheduled to open Wednesday in L'Aquila, Italy. The World Food Program (WFP) on Tuesday issued a statement praising the G8 leaders' focus on food security and calling for support of its efforts to combat hunger among the world's poorest people, Xinhua reports. In the statement, WFP Executive Director Josette Sheeran recommended leaders take a "twin-track" approach to food security, which includes supporting long-term agricultural production along with immediate hunger assistance.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Michelle Parish is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mrs Michelle Parish, APRN
5700 W Markham St,
Little Rock, AR 72205-3328

Ph: (501) 227-0184
Mrs Michelle Parish, APRN
5700 W Markham St,
Little Rock, AR 72205

Ph: (501) 227-0184

News Archive

UCSF scientists explore how Dact1 mutations contribute to psychiatric disorders

Gene mutations that cause cell signaling networks to go awry during embryonic development and lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism, and bipolar disorder, according to new research by UC San Francisco scientists.

Spider venom peptide could help stop pain in irritable bowel syndrome

Their study titled, "A spider-venom peptide with multi-target activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome," is published in the latest issue of the journal Pain.

Interleukin Genetics transfers stock trading from NYSE Amex to OTCQB Marketplace

Interleukin Genetics, Inc. today announced that trading of shares of the Company's common stock will be transferred from the NYSE Amex to the OTCQB™ Marketplace effective today, August 16, 2010. Investors in the Company can trade the stock easily in this marketplace, where Interleukin Genetics' symbol will now be ILIU.

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

G8 Summit begins Wednesday; WFP calls for 'twin-track' approach to food security

The G8 summit is scheduled to open Wednesday in L'Aquila, Italy. The World Food Program (WFP) on Tuesday issued a statement praising the G8 leaders' focus on food security and calling for support of its efforts to combat hunger among the world's poorest people, Xinhua reports. In the statement, WFP Executive Director Josette Sheeran recommended leaders take a "twin-track" approach to food security, which includes supporting long-term agricultural production along with immediate hunger assistance.

Read more News

› Verified 5 days ago


Nurse Practitioner Nurses in Little Rock, AR

Tammie R Glover-brockinton, APRN
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 4301 W Markham St, Little Rock, AR 72205
Phone: 501-686-7000    
Rachael Nichole Daugherty, APN/NP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1 Saint Vincent Cir, Suite 210, Little Rock, AR 72205
Phone: 501-552-4777    Fax: 501-552-4482
Lauren Searcy, DNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1 Childrens Way, Little Rock, AR 72202
Phone: 501-364-1100    
Ashley Benton, APRN
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 3 Chenal Heights Dr, Little Rock, AR 72223
Phone: 501-830-2271    
Rachel Sloan, APRN FNP-C
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205
Phone: 501-686-8000    
Elizabeth Fiser,
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 10025 W Markham St Ste 210, Little Rock, AR 72205
Phone: 501-663-5473    Fax: 501-801-1816

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.